These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 21995941)
1. An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice. Dang MT; Yokoi F; Cheetham CC; Lu J; Vo V; Lovinger DM; Li Y Behav Brain Res; 2012 Jan; 226(2):465-72. PubMed ID: 21995941 [TBL] [Abstract][Full Text] [Related]
2. Investigating the role of striatal dopamine receptor 2 in motor coordination and balance: Insights into the pathogenesis of DYT1 dystonia. Liu Y; Xing H; Yokoi F; Vaillancourt DE; Li Y Behav Brain Res; 2021 Apr; 403():113137. PubMed ID: 33476687 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the direct pathway in Dyt1 ΔGAG heterozygous knock-in mice and dopamine receptor 1-expressing-cell-specific Dyt1 conditional knockout mice. Yokoi F; Chen HX; Oleas J; Dang MT; Xing H; Dexter KM; Li Y Behav Brain Res; 2021 Aug; 411():113381. PubMed ID: 34038798 [TBL] [Abstract][Full Text] [Related]
4. Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia. Martella G; Maltese M; Nisticò R; Schirinzi T; Madeo G; Sciamanna G; Ponterio G; Tassone A; Mandolesi G; Vanni V; Pignatelli M; Bonsi P; Pisani A Neurobiol Dis; 2014 May; 65():124-32. PubMed ID: 24503369 [TBL] [Abstract][Full Text] [Related]
5. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice. Yokoi F; Oleas J; Xing H; Liu Y; Dexter KM; Misztal C; Gerard M; Efimenko I; Lynch P; Villanueva M; Alsina R; Krishnaswamy S; Vaillancourt DE; Li Y Neurobiol Dis; 2020 Feb; 134():104638. PubMed ID: 31618684 [TBL] [Abstract][Full Text] [Related]
6. Pre-synaptic release deficits in a DYT1 dystonia mouse model. Yokoi F; Cheetham CC; Campbell SL; Sweatt JD; Li Y PLoS One; 2013; 8(8):e72491. PubMed ID: 23967309 [TBL] [Abstract][Full Text] [Related]
7. Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors. Maltese M; Martella G; Madeo G; Fagiolo I; Tassone A; Ponterio G; Sciamanna G; Burbaud P; Conn PJ; Bonsi P; Pisani A Mov Disord; 2014 Nov; 29(13):1655-65. PubMed ID: 25195914 [TBL] [Abstract][Full Text] [Related]
8. Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia. Downs AM; Fan X; Donsante C; Jinnah HA; Hess EJ Neurobiol Dis; 2019 May; 125():115-122. PubMed ID: 30707939 [TBL] [Abstract][Full Text] [Related]
9. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Pisani A; Martella G; Tscherter A; Bonsi P; Sharma N; Bernardi G; Standaert DG Neurobiol Dis; 2006 Nov; 24(2):318-25. PubMed ID: 16934985 [TBL] [Abstract][Full Text] [Related]
10. Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia. DeAndrade MP; Trongnetrpunya A; Yokoi F; Cheetham CC; Peng N; Wyss JM; Ding M; Li Y Mov Disord; 2016 Nov; 31(11):1633-1639. PubMed ID: 27241685 [TBL] [Abstract][Full Text] [Related]
11. Reversal of motor-skill transfer impairment by trihexyphenidyl and reduction of dorsolateral striatal cholinergic interneurons in Yokoi F; Dang MT; Zhang L; Dexter KM; Efimenko I; Krishnaswamy S; Villanueva M; Misztal CI; Gerard M; Lynch P; Li Y IBRO Neurosci Rep; 2021 Dec; 11():1-7. PubMed ID: 34189496 [TBL] [Abstract][Full Text] [Related]
12. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Martella G; Tassone A; Sciamanna G; Platania P; Cuomo D; Viscomi MT; Bonsi P; Cacci E; Biagioni S; Usiello A; Bernardi G; Sharma N; Standaert DG; Pisani A Brain; 2009 Sep; 132(Pt 9):2336-49. PubMed ID: 19641103 [TBL] [Abstract][Full Text] [Related]
13. Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice. Yokoi F; Dang MT; Liu J; Gandre JR; Kwon K; Yuen R; Li Y Behav Brain Res; 2015 Feb; 279():202-10. PubMed ID: 25451552 [TBL] [Abstract][Full Text] [Related]
14. Improved motor performance in Dyt1 ΔGAG heterozygous knock-in mice by cerebellar Purkinje-cell specific Dyt1 conditional knocking-out. Yokoi F; Dang MT; Li Y Behav Brain Res; 2012 May; 230(2):389-98. PubMed ID: 22391119 [TBL] [Abstract][Full Text] [Related]
15. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia. Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876 [TBL] [Abstract][Full Text] [Related]
16. Dopamine release is impaired in a mouse model of DYT1 dystonia. Balcioglu A; Kim MO; Sharma N; Cha JH; Breakefield XO; Standaert DG J Neurochem; 2007 Aug; 102(3):783-8. PubMed ID: 17550429 [TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Dang MT; Yokoi F; McNaught KS; Jengelley TA; Jackson T; Li J; Li Y Exp Neurol; 2005 Dec; 196(2):452-63. PubMed ID: 16242683 [TBL] [Abstract][Full Text] [Related]
18. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia. Sciamanna G; Ponterio G; Tassone A; Maltese M; Madeo G; Martella G; Poli S; Schirinzi T; Bonsi P; Pisani A Neuropharmacology; 2014 Oct; 85():440-50. PubMed ID: 24951854 [TBL] [Abstract][Full Text] [Related]
19. Opposing patterns of abnormal D1 and D2 receptor dependent cortico-striatal plasticity explain increased risk taking in patients with DYT1 dystonia. Gilbertson T; Arkadir D; Steele JD PLoS One; 2020; 15(5):e0226790. PubMed ID: 32365120 [TBL] [Abstract][Full Text] [Related]
20. Cell-specific effects of Dyt1 knock-out on sensory processing, network-level connectivity, and motor deficits. Wilkes BJ; DeSimone JC; Liu Y; Chu WT; Coombes SA; Li Y; Vaillancourt DE Exp Neurol; 2021 Sep; 343():113783. PubMed ID: 34119482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]